The results showed that the expression of c-Myc in the high-dose SGHZF experimental group was significantly reduced compared to that in the control group, which indicates that SGHZF had an inhibitory effect on c-Myc in mouse breast cancer. This evidence concerns the gene MYC and breast carcinoma.